Literature DB >> 20530737

Caveolin-1-ablated mice survive in cold by nonshivering thermogenesis despite desensitized adrenergic responsiveness.

Charlotte L Mattsson1, Robert I Csikasz, Irina G Shabalina, Jan Nedergaard, Barbara Cannon.   

Abstract

Caveolin-1 (Cav1)-ablated mice display impaired lipolysis in white adipose tissue. They also seem to have an impairment in brown adipose tissue function, implying that Cav1-ablated mice could encounter problems in surviving longer periods in cold temperatures. To investigate this, Cav1-ablated mice and wild-type mice were transferred to cold temperatures for extended periods of time, and parameters related to metabolism and thermogenesis were investigated. Unexpectedly, the Cav1-ablated mice survived in the cold. There were no differences between Cav1-ablated and wild-type mice with regard to food intake, in behavior related to shivering, or in body temperature. The Cav1-ablated mice had a halved total fat content independently of acclimation temperature. There was no difference in brown adipose tissue uncoupling protein-1 (UCP1) protein amount, and isolated brown fat mitochondria were thermogenically competent but displayed 30% higher thermogenic capacity. However, the beta(3)-adrenergic receptor amount was reduced by about one-third in the Cav1-ablated mice at all acclimation temperatures. Principally in accordance with this, a higher than standard dose of norepinephrine was needed to obtain full norepinephrine-induced thermogenesis in the Cav1-ablated mice; the higher dose was also needed for the Cav1-ablated mice to be able to utilize fat as a substrate for thermogenesis. In conclusion, the ablation of Cav1 impairs brown adipose tissue function by a desensitization of the adrenergic response; however, the desensitization is not evident in the animal as it is overcome physiologically, and Cav1-ablated mice can therefore survive in prolonged cold by nonshivering thermogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530737     DOI: 10.1152/ajpendo.00071.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  7 in total

1.  Interaction with caveolin-1 modulates G protein coupling of mouse β3-adrenoceptor.

Authors:  Masaaki Sato; Dana S Hutchinson; Michelle L Halls; Sebastian G B Furness; Tore Bengtsson; Bronwyn A Evans; Roger J Summers
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

2.  Adipose tissue NAD+ biosynthesis is required for regulating adaptive thermogenesis and whole-body energy homeostasis in mice.

Authors:  Shintaro Yamaguchi; Michael P Franczyk; Maria Chondronikola; Nathan Qi; Subhadra C Gunawardana; Kelly L Stromsdorfer; Lane C Porter; David F Wozniak; Yo Sasaki; Nicholas Rensing; Michael Wong; David W Piston; Samuel Klein; Jun Yoshino
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-06       Impact factor: 11.205

3.  Detecting brown adipose tissue activity with BOLD MRI in mice.

Authors:  Arjun Khanna; Rosa T Branca
Journal:  Magn Reson Med       Date:  2012-01-09       Impact factor: 4.668

4.  Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1.

Authors:  Ingrid Wernstedt Asterholm; Dorothy I Mundy; Jian Weng; Richard G W Anderson; Philipp E Scherer
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

Review 5.  Caveolae as plasma membrane sensors, protectors and organizers.

Authors:  Robert G Parton; Miguel A del Pozo
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02       Impact factor: 94.444

6.  Distinct roles of endothelial and adipocyte caveolin-1 in macrophage infiltration and adipose tissue metabolic activity.

Authors:  Nolwenn Briand; Soazig Le Lay; William C Sessa; Pascal Ferré; Isabelle Dugail
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

7.  Caveolin-1 deficiency leads to increased susceptibility to cell death and fibrosis in white adipose tissue: characterization of a lipodystrophic model.

Authors:  Sally Martin; Manuel A Fernandez-Rojo; Amanda C Stanley; Michele Bastiani; Satomi Okano; Susan J Nixon; Gethin Thomas; Jennifer L Stow; Robert G Parton
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.